The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification

Antiviral Research

Volumn 59, Issue 1, 2003, Pages 23-33

  Oevermann, Anna ^a   Engels, Monika ^a   Thomas, Ursula ^a   Pellegrini, Antonio ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

3 Hydroxyphthalic anhydride; Antiviral; HSV 1; Lysozyme; Lactalbumin; Lactoglobulin

Indexed keywords

3 HYDROXYPHTHALIC ANHYDRIDE; ACID ANHYDRIDE; ALPHA LACTALBUMIN; BETA LACTOGLOBULIN; BOVINE SERUM ALBUMIN; CHYMOTRYPSIN; LYSOZYME; PEPSIN A; PEPTIDE FRAGMENT; PROTEIN; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONAVIRUS; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN MODIFICATION; RNA VIRUS INFECTION; VERO CELL; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS INHIBITION;

BOVINAE; BOVINE PARAINFLUENZA VIRUS 3; GALLUS GALLUS; HUMAN HERPESVIRUS 1; HUMAN PARAINFLUENZA VIRUS 3; SIMPLEXVIRUS; SUIDAE;

EID: 0038121718     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00010-X     Document Type: Article

References (49)

1. Aboudy Y., Mendelson E., Shalit I., Besalle R., Fridkin M. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Int. J. Pep. Protein Res. 43:1994;573-582.
2. Aysi N., Gupta S.V., Qualtiere L. Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds. J. Virol. Methods. 33:1991;335-344.
3. Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA. 85:1988;6132-6136.
4. Björk L., Grubb A., Kjellen L. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J. Virol. 64:1990;941-943.
5. Borenfreund E., Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red adsorption. Toxicol. Lett. 24:1985;119-124.
6. Carlucci M., Ciancia M., Matulewicz M., Cerezo A., Damonte E.B. Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antivir. Res. 43:1999;93-102.
7. Cocchi F., Lopez M., Dubreuil P., Campadelli Fiume G., Menotti L. Chimeric nectin 1-poliovirus receptor molecules identify a nectin 1 region functional in herpes simplex virus entry. J. Virol. 75:2001;7987-7994.
8. Dingwell K.S., Brunetti C.R., Hendricks R.L., Tang Q., Tang M., Rainbow A.J., Johnson D.C. Herpes simplex virus glycoprotein E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol. 68:1994;834-845.
9. Gil-Fernandez G., Perez S., Vilas P., Perez C., de las Heras F.G., Garcia Gancedo A. Antiviral activity of uridine 5′-diphosphate glucose analogues against some enveloped viruses in cell culture. Antivir. Res. 8:1987;299-310.
10. Gill S.F., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
11. Harmsen M.C., Swart P.J., de Béthune M.P., Pauwels R., De Clercq E., The T.H., Meijer D.K. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172:1995;380-388.
12. Herold B.C., WuDunn D., Soltys N., Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1991;1090-1098.
13. Isaacs C.E., Kascsak R., Pullarkat R.K., Xu W., Schneidman K. Inhibition of herpes simplex virus replication by retinoic acid. Antivir. Res. 33:1997;117-127.
14. Jansen R.W., Molema G., Pauwels R., Schols D., De Clercq E., Meijer D.K.F. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. Mol. Pharmacol. 39:1991;818-823.
15. Jansen R.W., Schols D., Pauwels R., De Clercq E., Meijer D.K.F. Novel negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity. Mol. Pharmacol. 44:1993;1003-1007.
16. Jiang, S., Li, Y.-Y., Lin, K., Strick, N., Neurath, R.A., George, K.S., Choudhury, S., Esmaeli-Azad, B., 1997. Virucidal and antibacterial activities of 3-HP-β-LG. In: Vaccines 97. Molecular Approaches to the Control of Infection Diseases, Cold Spring Harbor, Laboratory Press, Inc., pp. 327-330.
17. Kuipers M.E., Huisman J.G., Swart P.J., de Béthune M.P., Pauwels R., Schuitemaker H., De Clercq E., Meijer D.K.F. Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11:1996;419-429.
18. Kuipers M.E., van de Berg M., Swart P.J., Laman J.D., Meijer D.K.F., Koppelman M.H.G., Huisman H. Mechanism of anti-HIV activity of succinylated human serum albumin. Biochem. Pharmacol. 57:1999;889-898.
19. Lederman S., Gulick R., Chess R. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J. Immunol. 143:1989;1149-1154.
20. Marchetti M., Longhi C., Conte M.P., Pisani S., Valenti P., Seganti L. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antivir. Res. 29:1996;221-231.
21. Marchetti M., Pisani S., Antonini G., Valenti P., Seganti L., Orsi N. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus types 1 and 2. Biometals. 11:1998;89-94.
22. Marchetti M., Superti F., Ammendiola M.G., Rossi P., Valenti P., Seganti L. Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med. Microbiol. Immunol. 187:1999;199-204.
23. Matthews T.H.J., Lawrence M.K., Nair C.D.G., Tyrell D.A.J. Antiviral activity in milk of possible clinical importance. Lancet. ii:1976;1378-1389.
24. Neurath A.R., Debnath A.K., Strick N., Li Y.Y., Lin K., Jiang S. Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxis. J. Mol. Recognit. 8:1995;304-316.
25. Neurath A.R., Jiang S., Strick N., Lin K., Li Y.Y., Debnath A.K. Bovine β-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV. Nat. Med. 2:1996;230-234.
26. Neurath A.R., Debnath A.K., Strick N., Li Y.Y., Lin K., Jiang S. 3-Hydroxyphtaloyl-β-lactoglobulin. I. Optimization of production and comparison with other compounds considered for chemoprophylaxis of mucosally transmitted human immunodeficiency virus type 1. Antivir. Chem. Chemother. 8:1997;131-139.
27. Neurath A.R., Strick N., Li Y.Y. 3-Hydroxyphthaloyl-β-lactoglobulin. III Antiviral activity against herpesviruses. Antivir. Chem. Chemother. 9:1998;177-184.
28. Newburg D.S., Viscidi R.P., Ruff A., Yolken R.H. A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor. Pediatr. Res. 31:1992;22-28.
29. Patick A.K., Potts K.E. Protease inhibitors as antiviral agents. Clin. Microbiol. Rev. 11:1998;614-627.
30. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods. 20:1988;309-321.
31. Pellegrini A., Thomas U., Franchini M., Stöckli M., Klauser S., Hunziker P., von Fellenberg R. Identification of an aprotinin antiviral domain. FEBS Lett. 344:1994;261-265.
32. Pellegrini A., Thomas U., Bramaz N., Klauser S., Hunziker P., von Fellenberg R. Identification and isolation of the bactericidal domains in the proteinase inhibitor aprotinin. Biochem. Biophys. Res. Commun. 222:1996;559-565.
33. Pellegrini A., Thomas U., Bramaz N., Klauser S., Hunziker P., von Fellenberg R. Identification and isolation of a bactericidal domain in chicken egg white lysozyme. J. Appl. Microbiol. 82:1997;372-378.
34. Pellegrini A., Thomas U., Bramaz N., Hunziker P., von Fellenberg R. Isolation and identification of three bactericidal domains in the bovine α-lactalbumin molecule. Biochim. Biophys. Acta. 1426:1999;439-448.
35. Pellegrini A., Dettling C., Thomas U., Hunziker P. Isolation and characterization of four bactericidal domains in the bovine β-lactoglobulin. Biochim. Biophys. Acta. 1526:2001;131-140.
36. Reed L., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
37. Seong-Ku E., Young-So K., Chong-Kil L., Seong-Sun H. Antiherpetic activities of various protein bound polysaccharides isolated from Ganoderma lucidum. J. Ethnopharm. 68:1999;175-181.
38. Shieh M.T., WuDunn D., Montgomery R.I., Esko J.D., Spear P.G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1992;1273-1281.
39. Superti F., Ammendolia M.G., Valenti P., Seganti L. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. 186:1997;83-91.
40. Swart P.J., Kuipers E.M., Smit C., Pauwels R., de Béthune M.P., De Clercq E., Meijer D., Huismann J.G. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus type 1 and 2 in vitro. AIDS Res. Hum. Retroviruses. 12:1996;769-775.
41. Swart P.J., Harmsen M.C., Kuipers M.E., Van Dijk A.A., Van der Strate W.A., Van Berkel P.H.C., Nuijens J.H., Smit C., Witvrouw M., De Clercq E., de Béthune M.-P., Pauwels R., Meijer D.K.F. Charge modification of plasma and milk proteins results in antiviral active compounds. J. Pept. Sci. 5:1999;563-576.
42. Takami M., Sone T., Mizumoto K., Kino K., Tsunoo H. Maleylated human serum albumin inhibits HIV-1 infection in vitro. Biochim. Biophys. Acta. 1180:1992;180-186.
43. Trybala E., Bergstrom T., Svennerholm B., Jeansson S., Glorioso J.C., Olofsson S. Localization of a functional site on herpes simplex virus 1 glycoprotein C involved in binding to cell surface heparan sulphate. J. Gen. Virol. 75:1994;743-752.
44. Ueno R., Kuno S. Dextran sulfate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet. 13:1987;1379.
45. Valenti, P., Marchetti, M., Superti, F., Amendiola, M.G., Puddu, P., Gessani, S., Borghi, P., Belardelli, F., Antonini, G., Seganti, L., 1998. Antiviral activity of lactoferrin. In: Spik, G., Legrand, D., Mazurier, J., Pierce, A., Perraudin, J.P. (Eds.), Advances in Lactoferrin Research, Plenum Press, New York, pp. 199-203.
46. Viani R.M., Gutteberg T.J., Lathey J.L., Spector S.A. Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine. AIDS. 13:1999;1273-1285.
47. Wachsman M.B., Lopez E., Ramirez J., Galagovsky L.R., Coto C.E. Antiviral effect of brassinosteroids against herpes virus and arena viruses. Antivir. Chem. Chemother. 11:2000;71-77.
48. Weeks B.S., Sundaresan P., Nagashunmugam T., Kang E., Friedman H.M. The herpes simplex virus-1 glycoprotein E (gE) mediates IgG binding and cell-to-cell spread through distinct gE domains. Biochem. Biophys. Res. Communn. 235:1997;31-35.
49. WuDunn D., Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:1989;52-58.